Xeljanz

Xeljanz Campaign Details

Prices listed are the current retail value and may be higher or lower based on availability, size of budget, demand, volatility and additional filters.

  • Xeljanz lead
    Call for pricing
  • Xeljanz signed
    Call for pricing

Xeljanz Criteria

  • Took Xeljanz or Xeljanz XR (tofacitinib) for RA between 2013 and 2019
  • Suffered from any of the following while on the medication
    • Blood clots
    • Heart attack
    • Stroke
    • DVT
    • PE
    • Death
  • Hospitalized for injuries related to medication usage
  • No legal representation

Xeljanz Background Information

Treatment for

Rheumatoid Arthritis (approved Nov 2012) , Psoriatic Arthritis (approved Dec 2017), Ulcerative Colitis (approved June 2018)

Immunosuppressive medication

Xeljanz and Xeljanz XR are immunosuppressive medications that work by inhibiting enzymes (JAK-1 & JAK-3) that signal certain immune responses that may contribute to arthritis and/or colitis. Because Xeljanz impacts the immune system, the risk of serious infection has always been a concern. Health risks related to blood clots in the lungs or pulmonary embolisms were not published by Pfizer.

February 2019

A MedWatch FDA warning was issued to alert patients and doctors of a public safety study that has shown an increased risk of pulmonary embolism in patients with Rheumatoid Arthritis when taking the 10mg dosage twice daily. The FDA approved the 10mg dosage for Ulcerative Colitis but did not approve the 10mg dosage for RA.

Manufacturer

Pfizer

Generic Name

tofacitinib

Symptoms & Side Effects

  • Sudden shortness of breath or difficulty breathing
  • Chest pain or pain in your back
  • Coughing up blood
  • Excessive sweating
  • Clammy or bluish colored skin

Injuries

  • Blood clots
  • Heart attack
  • Stroke
  • DVT
  • PE
  • Death

CONTACT US

We welcome you to contact Mass Torts USA for more information
about our products and services.